Literature DB >> 15010027

Marginal Zone B-cell Lymphoma (MALT Lymphoma).

Patrick D. Hung1, Mitchell L. Schubert, Anastasios A. Mihas.   

Abstract

The preferred terminology for mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach (variously referred to as MALT lymphoma, MALToma, low-grade MALToma, or pseudolymphoma) is marginal zone B-cell lymphoma (MZBL). MZBL, the hallmark of which is the lymphoepithelial lesion, develops as a consequence of Helicobacter pylori infection in susceptible individuals. In general, MZBL is slow growing, can remain localized for years, and has an excellent prognosis. Staging involves endoscopy with biopsy, computed tomography scanning, and endoscopic ultrasound. In patients with limited disease, eradication of H. pylori leads to remission. In patients who fail eradication therapy or have more extensive disease, surgery, chemotherapy, and radiation alone and in various combinations have been used successfully.

Entities:  

Year:  2004        PMID: 15010027     DOI: 10.1007/s11938-004-0034-0

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  50 in total

1.  Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.

Authors:  W W Ng; C P Lam; W K Chau; A Fen-Yau Li; C C Huang; F Y Chang; S D Lee
Journal:  Gastrointest Endosc       Date:  2000-01       Impact factor: 9.427

2.  Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.

Authors:  M Sackmann; A Morgner; B Rudolph; A Neubauer; C Thiede; H Schulz; W Kraemer; G Boersch; P Rohde; E Seifert; M Stolte; E Bayerdoerffer
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

3.  Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone.

Authors:  N R Schechter; C S Portlock; J Yahalom
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

4.  Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically.

Authors:  M Lévy; P Hammel; D Lamarque; O Marty; M T Chaumette; C Haioun; M Blazquez; J C Delchier
Journal:  Gastrointest Endosc       Date:  1997-10       Impact factor: 9.427

Review 5.  Gastric lymphoma: the revolution of the past decade.

Authors:  H Boot; D de Jong
Journal:  Scand J Gastroenterol Suppl       Date:  2002

6.  Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy.

Authors:  A Savio; G Zamboni; P Capelli; R Negrini; G Santandrea; A Scarpa; A Fuini; F Pasini; A Ambrosetti; A Paterlini; F Buffoli; G P Angelini; P Cesari; F Rolfi; M Graffeo; A Pascarella; M Valli; A Mombello; A Ederle; G Franzin
Journal:  Recent Results Cancer Res       Date:  2000

7.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.

Authors:  T Radaszkiewicz; B Dragosics; P Bauer
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

Review 8.  Mucosa-associated lymphoid tissue lymphoma.

Authors:  P G Isaacson
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

9.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

10.  Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry.

Authors:  K A Gurney; R A Cartwright; E A Gilman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.